Acino Holding AG : Acino appoints new Head Group Quality and Member of Group Management

NEWS RELEASE - PRESSEMITTEILUNG

Acino appoints new Head Group Quality and Member of Group Management Basle, December 6, 2012, 07.00 hrs - Acino appoints Dr. Stefan Bier as its new Head Group Quality and a Member of Group Management effective April 1, 2013. In this function he will be responsible for the Group-wide quality assurance and compliance in product development and at all manufacturing sites as well as pharmacovigilance. He succeeds Dr. Ulf-Hergen Westphal who will leave the company at his own request to pursue career opportunities outside the Acino Group.

Dr. Stefan Bier can look back on over 20 years of experience in quality assurance and compliance with several renowned pharmaceutical companies including Swiss-based Ferring Pharmaceuticals, his last appointment, and Sandoz International. His proven track record in providing strong QA leadership and establishing global quality assurance networks across sites and functions will be invaluable to the Acino Group as it expands operations around the globe.

For additional information please consult Dr. Stefan Biers full profile under www.acino- pharma.com.

Acino - Delivering Health

Acino (SIX: ACIN), a Swiss-based pharmaceutical company, develops, manufactures and interna- tionally markets well-proven and innovative pharmaceuticals in novel drug delivery forms. Acino is a leader in advanced drug delivery technologies with a focus on modified release oral forms, oral dispersible forms, transdermal systems and extended release parenterals, for which it also holds patents. As a partner of pharmaceutical companies worldwide, Acino supplies finished in-house developed products and/or provides customized one-stop solutions from product development and registration to contract manufacturing, packaging and logistics. Under the brand "Acino Switzer- land", Acino markets Swiss-quality medicines in up and coming economies, currently in 80 coun- tries in the Middle East, Africa, Latin America and Asia. The Acino Group is headquartered in Basle, at present has about 850 employees and generated revenues of EUR 129 million in the first half- year 2012.

Contact Calendar

Robert Schmid
Media & Investor Relations Phone [phone] [e-mail]
www.acino-pharma.com

7.3.2013 Annual Report 2012
7.3.2013 Media and analyst conferences
4.4.2013 General Meeting of Shareholders

Acino Holding Ltd.

Erlenstrasse 1

CH-4058 Basle

Phone [phone]

Fax [phone] www.acino-pharma.com